Clinical Trials Logo

Clinical Trial Summary

Renal functional reserve is defined as the glomerular hyper filtration induced by a protein load. Renal blood flow and Glomerular Filtration Rate (GFR) increase in response to a protein load. Renal functional reserve loss is associated with a persistent hyper filtration state, seen in first stages of diabetic nephropathy, leading to progression of Chronic Kidney Disease (CKD). This observation has lead to larger clinical studies that demonstrated the positive effects of protein restriction on kidney function, and allowed the scientific community to recommend low proteins diet (less than 0.8 g / kg/ day) to prevent CKD progression. Nevertheless, the precise mechanisms responsible for kidney hemodynamic and metabolic changes induced by a protein load, are debated. Uribarri et al have suggested that renal hemodynamic changes induced by a protein load are mainly due to the Advanced Glycation End Products (AGEs) content. Indeed, initial studies experimental conditions leading to the demonstration of renal functional reserve (amino acid or protein perfusion or cooked meat), were in fact responsible for an AGEs load, based on recent published data.

The aim of this study is to determine whether AGEs alone or proteins in general are responsible for the mobilization of renal functional reserve, leading to the progression of CKD.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02695251
Study type Interventional
Source Hospices Civils de Lyon
Contact
Status Completed
Phase N/A
Start date February 2016
Completion date July 2016

See also
  Status Clinical Trial Phase
Recruiting NCT06274125 - Evaluation of Kidney Damage Using NGAL Measurements
Terminated NCT03152084 - The Study Will Evaluate Average 24-hr Sodium Excretion During Dapagliflozin Treatment in Patients With Type 2 Diabetes Mellitus With Preserved or Impaired Renal Function or Non-diabetics With Impaired Renal Function. Phase 4
Completed NCT02306213 - Effect of Hydroxyethylstarch 6% 130/0.4 Administration on Renal Function After Cardiac Surgery N/A
Active, not recruiting NCT05232188 - Effect of Renal Access Sheath on Functions N/A